CU20090182A7 - NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION - Google Patents

NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Info

Publication number
CU20090182A7
CU20090182A7 CU20090182A CU20090182A CU20090182A7 CU 20090182 A7 CU20090182 A7 CU 20090182A7 CU 20090182 A CU20090182 A CU 20090182A CU 20090182 A CU20090182 A CU 20090182A CU 20090182 A7 CU20090182 A7 CU 20090182A7
Authority
CU
Cuba
Prior art keywords
hepatitis
methods
virus replication
macrocyclic inhibitors
new macrocyclic
Prior art date
Application number
CU20090182A
Other languages
Spanish (es)
Inventor
Bin Wang
April Kennedy
Robert Kaus
Kevin CONDROSKI
Steve W Andrews
Scott Seiwert
Timothy Kercher
Jyanwei Liu
Lin Pan
Michael Lyon
Pierre Martin
Leonid Beigelman
Yutong Jiang
Lawrence M Blatt
Andreas Schumacher
Original Assignee
Intermune Inc
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Inc, Array Biopharma Inc filed Critical Intermune Inc
Priority to CU20090182A priority Critical patent/CU20090182A7/en
Publication of CU20090182A7 publication Critical patent/CU20090182A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compuestos de fórmula general I, y composiciones, incluyendo composiciones farmacéuticas, que comprenden dicho compuesto. Además, en las modalidades se proporcionan métodos de tratamiento, incluyendo métodos para tratar una infección de virus de hepatitis C y métodos para tratar la fibrosis hepática, donde los métodos generalmente comprenden administrarle a un individuo que lo necesita una cantidad eficaz del compuesto o la composición mencionada.Compounds of general formula I, and compositions, including pharmaceutical compositions, comprising said compound. In addition, treatment methods are provided in the modalities, including methods to treat a hepatitis C virus infection and methods to treat liver fibrosis, where the methods generally comprise administering to an individual in need an effective amount of the compound or composition. mentioned.

CU20090182A 2009-11-03 2009-11-03 NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION CU20090182A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20090182A CU20090182A7 (en) 2009-11-03 2009-11-03 NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20090182A CU20090182A7 (en) 2009-11-03 2009-11-03 NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Publications (1)

Publication Number Publication Date
CU20090182A7 true CU20090182A7 (en) 2011-05-27

Family

ID=44306255

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090182A CU20090182A7 (en) 2009-11-03 2009-11-03 NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Country Status (1)

Country Link
CU (1) CU20090182A7 (en)

Similar Documents

Publication Publication Date Title
ECSP099780A (en) NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
CU20100203A7 (en) NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
ECSP099792A (en) NEW INHIBITING PEPTIDES FOR HEPATITIS C VIRUS REPLICATION
ECSP12011845A (en) NEW MACROCYCLIC INHIBITORS OF REPLICATION
CU20090209A7 (en) MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
ECSP088208A (en) NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
ECSP066570A (en) MACROCYCLIC AND ACILSULPHONAMID CARBOXYLIC ACIDS AS HCV REPLICATION INHIBITORS
MX2012003171A (en) Novel macrocyclic inhibitors of hepatitis c virus replication.
WO2012087976A3 (en) Novel inhibitors of hepatitis c virus replication
DOP2014000133A (en) SUBSTITUTED TRIAZOLOPIRIDINS
MX2009008439A (en) Novel inhibitors hepatitis c virus replication.
CL2012001960A1 (en) Thiophene-2-carboxylic acid derivative compounds; flaviviridae virus inhibitors; pharmaceutical composition comprising them; Useful in the treatment of hepatitis c. pct national phase
ECSP12011935A (en) TRIAZOLOPIRIDINS
EA201490228A1 (en) NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
CU20090112A6 (en) MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
UY33452A (en) REPLACED TRIAZOLOPIRIDINS
DOP2013000244A (en) TRIAZOLOPIRIDINS
WO2009134616A3 (en) Novel inhibitors of hepatitis c virus replication
UY33790A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND MEK INHIBITOR.
CU20090182A7 (en) NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
NI200700218A (en) AMIDA DERIVATIVES AS LIGANDS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME.
CU20090188A7 (en) NEW INHIBITING PEPTIDES OF HEPATITIS C VIRUS REPLICATION
CU23602A3 (en) MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
CR10204A (en) DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME
ECSP088739A (en) DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME